Parsh Jessica, Seth Milan, Green Jacqueline, Sutton Nadia R, Chetcuti Stanley, Dixon Simon, Grossman Paul M, Khandelwal Akshay, Dupree James M, Gurm Hitinder S
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.
Department of Cardiovascular Medicine, Beaumont Hospital, Royal Oak, Michigan.
Catheter Cardiovasc Interv. 2017 May;89(6):966-973. doi: 10.1002/ccd.26917. Epub 2017 Feb 1.
We sought to evaluate the incidence, risk factors, in-hospital, and long-term outcomes and predictors of mortality of coronary artery perforations (CAP) in the contemporary percutaneous coronary intervention (PCI) era.
CAP is a rare but serious complication of PCI associated with increased risk of morbidity and mortality.
We included 181,590 procedures performed across 47 hospitals in Michigan from January 1, 2010 to December 31, 2015. Endpoints evaluated included the incidence of CAP and its association with in-hospital outcomes. Logistic regression analysis was utilized to determine independent risk factors for CAP and to examine whether the effect of CAP on mortality varied by gender.
CAP occurred in 625 (0.34%) patients. Independent predictors for CAP included older age, peripheral arterial disease, presence of left ventricular dysfunction or cardiomyopathy, lower body mass index, pre-PCI insertion of a mechanical ventricular support device, treatment of complex lesions (Type C), and treatment of chronic total occlusions, the latter of which was the strongest predictor of perforation (adjusted odds ratio (OR) 7.01, P < 0.001). After adjusting for baseline risk, the incidence of adverse outcomes remained substantially greater in patients with a perforation, with an adjusted OR estimate of 5.00 for mortality (95% CI 3.42-7.31), 3.25 for acute kidney injury (95% CI 2.30-4.58), and 5.26 for transfusion (95% CI 4.03-6.87) (all P < 0.001). Perforation was associated with a higher mortality in women than men (interaction P value = 0.01).
CAP is a rare complication but is associated with high morbidity and mortality especially in women. Further investigation is warranted to determine why women fare worse after CAP. © 2017 Wiley Periodicals, Inc.
我们试图评估当代经皮冠状动脉介入治疗(PCI)时代冠状动脉穿孔(CAP)的发生率、危险因素、院内及长期结局以及死亡预测因素。
CAP是PCI的一种罕见但严重的并发症,与发病和死亡风险增加相关。
我们纳入了2010年1月1日至2015年12月31日在密歇根州47家医院进行的181,590例手术。评估的终点包括CAP的发生率及其与院内结局的关联。采用逻辑回归分析来确定CAP的独立危险因素,并检验CAP对死亡率的影响是否因性别而异。
625例(0.34%)患者发生了CAP。CAP的独立预测因素包括年龄较大、外周动脉疾病、存在左心室功能障碍或心肌病、较低的体重指数、PCI前植入机械心室支持装置、复杂病变(C型)的治疗以及慢性完全闭塞病变的治疗,其中后者是穿孔的最强预测因素(调整后的比值比(OR)为7.01,P < 0.001)。在调整基线风险后,穿孔患者不良结局的发生率仍然显著更高,死亡率的调整后OR估计值为5.00(95%CI 3.42 - 7.31),急性肾损伤为3.25(95%CI 2.30 - 4.58),输血为5.26(95%CI 4.03 - 6.87)(所有P < 0.001)。穿孔与女性的死亡率高于男性相关(交互P值 = 0.01)。
CAP是一种罕见的并发症,但与高发病率和死亡率相关,尤其是在女性中。有必要进一步研究以确定CAP后女性预后较差的原因。© 2017威利期刊公司